title: Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.
authors.forename: P
authors.initials: P
authors.lastname: le Coutre
authors.forename: K A
authors.initials: KA
authors.lastname: Kreuzer
authors.forename: G
authors.initials: G
authors.lastname: Massenkeil
authors.forename: G
authors.initials: G
authors.lastname: Baskaynak
authors.forename: P
authors.initials: P
authors.lastname: Zschieschang
authors.forename: I
authors.initials: I
authors.lastname: Genvresse
authors.forename: J
authors.initials: J
authors.lastname: Lupberger
authors.forename: M
authors.initials: M
authors.lastname: Mapara
authors.forename: B
authors.initials: B
authors.lastname: Dörken
authors.forename: R
authors.initials: R
authors.lastname: Arnold
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate